There are no early stage diagnostics for ovarian cancer and by the time they are discovered, they may not respond to standard cancer treatments. But a new research from A*STAR's Institute of Medical Biology (IMB) and the Bioinformatics Institute (BII) have found new clues to early detection and personalized treatments of ovarian cancer, thus offering hope to millions of women who might be susceptible to it. Their findings were published online in Nature Cell Biology in July 2014.
Community
Condition
